NCT06515431

Brief Summary

Kidney removal for cancer (nephrectomy) is a major operation. People can develop heart complications during or after surgery, especially if they are older or already have heart disease. One form of heart damage is called myocardial injury (MINS). This can be detected with a simple and easily available blood test. Unlike a heart attack, MINS doesn't cause changes in the electrical tracing of the heart (ECG) and it typically doesn't cause symptoms like pain. However, it can lead to heart problems and a stroke after surgery. We do not know how many people having a nephrectomy develop MINS. It is important to know if people are at high risk of MINS to help decide future treatment. There are a few different ways of carrying out nephrectomy surgery. These can be traditional open surgery, keyhole surgery or robotic surgery. We know that MINS is more likely if there has been a lot of bleeding during the operation, but other factors are also important. Therefore, it's important to monitor the relationship between blood loss, rates of MINS and method of surgery. We aim to recruit 120 participants undergoing nephrectomy to see how many develop MINS and to compare blood loss between different ways of surgery. Patients will be asked to consent to have blood tests on the day of and the day after surgery. This test will be added to routine hospital blood tests (and so no extra samples are needed). These results will show how many patients are diagnosed with MINS after nephrectomy. Around 90 days after the surgery, their quality of life and any further heart or breathing problems will also be recorded. We hope to identify the rates of and risk factors for MINS, so future patients can be spared this complication of surgery.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 16, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 17, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 23, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

September 9, 2025

Status Verified

January 1, 2025

Enrollment Period

12 months

First QC Date

July 17, 2024

Last Update Submit

September 2, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients undergoing radical nephrectomy with evidence of myocardial injury (MINS)

    This will be defined as a raised troponin level \>99th percentile upper reference limit on any sample taken within 72 hours following the operation.

    72 hours post surgery

Secondary Outcomes (4)

  • Occurrence of intraoperative and post-operative blood transfusion

    72 hours post surgery

  • Number of days out of hospital

    90 days post surgery

  • Rate of major adverse cardiac events (MACE)

    90 days post surgery

  • Impact on quality of life, assessed by EQ-5D-5L questionnaire completed by patients

    90 days post surgery

Study Arms (2)

Laparoscopic nephrectomy

Robotic nephrectomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Surgery waiting lists will be screened by members of the research team at Sheffield Teaching Hospitals to identify patients that will be undergoing a radical nephrectomy for suspected renal cancer. The surgical approach will already have been decided before the study is introduced. Those eligible will be contacted via phone to discuss the study further.

You may qualify if:

  • Adult patients (aged 18 and above)
  • Undergoing a radical nephrectomy (either laparoscopic or robotic) for suspected renal cancer
  • Stage \<T3a
  • Can provide informed consent

You may not qualify if:

  • Patients under 18
  • Undergoing partial nephrectomy
  • Undergoing radical nephrectomy not for suspected renal cancer
  • Unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sheffield Teaching Hospitals NHS Foundation Trust

Sheffield, S10 2JF, United Kingdom

Location
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2024

First Posted

July 23, 2024

Study Start

April 16, 2024

Primary Completion

March 31, 2025

Study Completion

June 1, 2025

Last Updated

September 9, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations